XF-73
id:
xf-73-306-8861260
title:
XF-73
text:
XF-73 is an experimental drug candidate. It is an anti-microbial that works via weakening bacteria cell walls. It is a potential treatment for methicillin-resistant Staphylococcus aureus (MRSA) and possibly Clostridium difficile. It is being developed by Destiny Pharma Ltd. Structurally, it is a dicationic porphyrin. It has completed a phase I clinical trial for nasal decolonisation of MRSA—being tested against 5 bacterial strains. It seems unlikely to cause MRSA to develop resistance to it. In
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/XF-73
date created:
date modified:
2022-07-04T01:58:01Z
main entity:
{"identifier":"Q8041945","url":"https://www.wikidata.org/entity/Q8041945"}
image:
fields total:
13
integrity:
14